An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide).
An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide). Cancer Discov. 2013 Sep; 3(9):1030-43.